Amphotericin b, liposomal

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Liposomal amphotericin

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Liposomal encapsulated Amphotericin B.

IndicationThis section has been translated automatically.

Aspergillosis, cryptococcal meningitis ( cryptococcosis), if conventional amphotericin B therapy is contraindicated due to kidney damage or for other reasons

Limited indicationThis section has been translated automatically.

Pregnancy, nursing.

Dosage and method of useThis section has been translated automatically.

On the 1st day 1 mg/kg bw i.v., then increase to 2-3 mg/kg bw, corresponding dosage in children.

Undesirable effectsThis section has been translated automatically.

Compared to Amphotericin B rarely urea and creatinine increase. S.a.a. under Amphotericin B.

ContraindicationThis section has been translated automatically.

Hypersensitivity to active substance or ingredients.

PreparationsThis section has been translated automatically.

AmBisome

Authors

Last updated on: 29.10.2020